Clinical features and APOE genotype of pathologically proven early-onset Alzheimer disease.
about
Early-onset Alzheimer's disease: nonamnestic subtypes and type 2 ADA Unified Hypothesis of Early- and Late-Onset Alzheimer's Disease PathogenesisAutosomal Dominant Alzheimer Disease: A Unique Resource to Study CSF Biomarker Changes in Preclinical ADThe corticobasal syndrome-Alzheimer's disease conundrumPolygenic Analysis of Late-Onset Alzheimer's Disease from Mainland China.Alzheimer's disease first symptoms are age dependent: Evidence from the NACC dataset.The behavioural/dysexecutive variant of Alzheimer's disease: clinical, neuroimaging and pathological features.R47H TREM2 variant increases risk of typical early-onset Alzheimer's disease but not of prion or frontotemporal dementiaComparison of clinical characteristics between familial and non-familial early onset Alzheimer's disease.A longitudinal study of physical function in patients with early-onset dementia.Nonamnestic presentations of early-onset Alzheimer's diseaseGenetic mediators of neurocognitive outcomes in survivors of childhood acute lymphoblastic leukemiaFinancial errors in dementia: testing a neuroeconomic conceptual framework.A clinical approach to early-onset inheritable dementia.The paradox of syndromic diversity in Alzheimer disease.Uncommon and/or bizarre features of dementia.Diagnostic accuracy of behavioral variant frontotemporal dementia consortium criteria (FTDC) in a clinicopathological cohort.Confluence of α-synuclein, tau, and β-amyloid pathologies in dementia with Lewy bodies.Increasing Precision of Clinical Diagnosis of Alzheimer's Disease Using a Combined Algorithm Incorporating Clinical and Novel Biomarker Data.Approach to atypical Alzheimer's disease and case studies of the major subtypes.In their own words: The experience and needs of children in younger-onset Alzheimer's disease and other dementias families.Multimodal PET Imaging of Amyloid and Tau Pathology in Alzheimer Disease and Non-Alzheimer Disease Dementias.Cerebrospinal Fluid Biomarkers in Alzheimer's Disease-From Brain Starch to Bench and Bedside.Cerebral Hypoperfusion and Hypometabolism Detected by Arterial Spin Labeling MRI and FDG-PET in Early-Onset Alzheimer's Disease.Early- versus late-onset Alzheimer's disease in clinical practice: cognitive and global outcomes over 3 years.Differences between early and late onset Alzheimer's disease.Does Alzheimer's disease with early onset progress faster than with late onset? A case-control study of clinical progression and cerebrospinal fluid biomarkers.[18 F]AV-1451 clustering of entorhinal and cortical uptake in Alzheimer's disease.Association of the CX3CR1-V249I Variant with Neurofibrillary Pathology Progression in Late-Onset Alzheimer's Disease.A Common Variant in the MC1R Gene (p.V92M) is associated with Alzheimer's Disease Risk.Regional Overlap of Pathologies in Lewy Body Disorders.Differentiated clinical presentation of early and late-onset Alzheimer's disease: is 65 years of age providing a reliable threshold?Olfactory and Imaging Features in Atypical Alzheimer's Disease.Posterior cortical atrophy
P2860
Q22252525-2D411350-F22A-4E49-AAB7-08D2B645D730Q26781496-0D07F68F-6785-4F72-899C-2DC31C897456Q26801666-C74D9C82-B9AB-4468-93AD-7306A84C2EE9Q28250881-B6EDD67B-2C40-487E-9884-997ABB1E9474Q35872461-80264A7B-D704-4522-8559-A2CB265068D2Q36202834-40AB932B-CD30-46AF-BFC9-08747E4A699BQ36217479-3B0CA7F7-24CD-4F93-A007-39DA528F807BQ36232670-83EC8367-13EB-4395-A2AB-FEF70B9A1D3DQ36233510-D8ECBA37-14C0-46A0-9D76-84E3DC012B5EQ36551480-6DAAD119-91DD-4EA0-BD61-4E79E6D76C26Q36763709-DD78F178-D5FB-4248-93BB-6D2F9F926EEAQ37065825-6CBFF22B-BA38-4C5A-8BEE-F6394DD26DBAQ37164711-4BF7A887-4AA1-4727-B363-4007BA9ADBCEQ38008963-D72D1918-72B9-4890-B9E5-9AB0E65BE95BQ38026786-ACCC7F6B-7796-4662-87C0-D34E0B606005Q38213992-189034E6-5A9D-4E31-9786-991F78386772Q38266291-F5707CE1-9926-42B6-949B-0827A6B17363Q38311234-08710A54-20A3-420D-A81F-038FACF4E280Q38666998-ECE739EA-AD95-4FDD-BAEB-6E13CAC26E50Q39135327-1F8A0A7F-4761-43BE-BC5E-328C7EFF4D07Q39291539-BB52B695-782A-43D6-9F88-11F147FED58CQ39346750-52ADA6F3-9CAB-44DA-BCC8-080B43620DECQ39432592-B03261E7-8CD2-401F-AA9E-F1D4F1B0C220Q40881715-873F2D09-54FF-46BB-AA67-34B12C0818AAQ41588156-8831672F-EE5B-4C08-83D2-E64D25B09FC3Q42043147-47B3036A-2B8F-4560-AE3A-3A466C7CD6F9Q43479548-5D29B8EE-CA14-4F62-99CB-3D513F15433EQ48261458-4B844C5E-64B7-4E41-94F5-9008D29A5119Q48361868-19A0F670-CCDD-4E95-97EE-141E6F9320FAQ48369672-A151419A-BBC9-486B-BD44-1C74635AE569Q50211142-54DE95AE-B186-4D58-9962-070FDAAA8E69Q50595516-5CB9F76A-60AE-4805-94E6-F53781AABC1FQ52665575-0BFC3B9C-F1D1-47BA-8232-80BCB7BA9135Q57384523-7BF0A693-A8CE-411C-9F25-F29541296004
P2860
Clinical features and APOE genotype of pathologically proven early-onset Alzheimer disease.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on May 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Clinical features and APOE gen ...... early-onset Alzheimer disease.
@en
Clinical features and APOE gen ...... early-onset Alzheimer disease.
@nl
type
label
Clinical features and APOE gen ...... early-onset Alzheimer disease.
@en
Clinical features and APOE gen ...... early-onset Alzheimer disease.
@nl
prefLabel
Clinical features and APOE gen ...... early-onset Alzheimer disease.
@en
Clinical features and APOE gen ...... early-onset Alzheimer disease.
@nl
P2093
P50
P1433
P1476
Clinical features and APOE gen ...... early-onset Alzheimer disease
@en
P2093
Neurological Tissue Bank/Unive ...... NTB/UB/HC Collaborative Group
P304
P356
10.1212/WNL.0B013E31821A44DD
P407
P577
2011-05-01T00:00:00Z